who makes ozempic semaglutide is first GLP-1 drug FDA-approved for kidney disease Type 2 diabetes: New Ozempic

The UK SmPCs for semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro), as well as their EMA European Public Assessment Reports (EPARs), document well-characterised GI side effect profiles that include nausea, vomiting, diarrhoea, constipation, and dyspepsia

23 May SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1/ GIP Medicines Pretoria, 23 May 2026 The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination product containing both Semaglutide and Tirzepatide promoted for weight loss

Like at this point, I and many of you who listen to this show, if you've listened to it long enough, you almost don't pay attention when someone says, Oh, this is bad, this is bad, this is bad

For women who have been interested in weight loss treatment but hesitant about injections, this could mark an important new chapter